theravance.com (TBPH): Rega marang bathi kanthi panyesuaian wutah

Simbol lan logo merek Theravance Biopharma (TBPH)

Theravance Biopharma management focuses on developing safe organ-selective agents for the therapy of respiratory and gastrointestinal tracts. The company relies on stable royalties from Yupelri, possessing significant pricing power. The developer's strong authority is confirmed by the PEG growth potential ratio, where the value is maintained at 0.00, allowing for a pragmatic assessment of the company's market value.

TBPH - Pangali PEG Theravance Biopharma Inc ing rentang 04.07.2022 - 10.10.2026

Rincian metrik lan analitis perusahaan Theravance Biopharma, Inc. (TBPH)

- rega saham lan konsensus proyeksi valuasi:
Ringkesan analitik perusahaan:Theravance
Produk seri theravance.com

Amidst price wars in the respiratory therapy segment and pressure from generics, the resilience of Theravance Biopharma (TBPH) depends on its ability to convert patient loyalty into profit growth. The PEG ratio trend compares the current P/E with earnings growth rates: values below one signal that the asset is undervalued relative to its expansion. Analysis of this chart reveals the company's fundamental potential, separating market noise from real operational efficiency.

Perusahaan pesaing

HLN - Rega marang bathi kanthi panyesuaian wutah|Rasio rega marang bathi tumrap wutah Kenvue Inc KVUE|Verona Pharma (VRNA) - Rega marang bathi kanthi panyesuaian wutah|MENS: Pangali rega marang bathi tumrap wutah|Ligand - Rasio nilai perusahaan marang wutah bathi|AMRX: Pangali PEG|Perrigo Company - Koefisien bali modal nimbang wutah|ALVO (Alvotech S.A.) - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah liquidia.com LQDA|Rasio rega marang bathi tumrap wutah Galapagos (GLPG)|ANIP (ANI Pharmaceuticals, Inc.) - Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah Afrezza MNKD|Pangali PEG Amphastar Corp AMPH|Pacira Corp - Pangali PEG|Koefisien bali modal nimbang wutah SPRY (ars-pharma.com)|AQST (aquestive.com) - Pangali rega marang bathi tumrap wutah|Rasio kapitalisasi marang bathi lan wutah SCPH (scPharmaceuticals, Inc.)|Pangali rega marang bathi tumrap wutah TECX|Tonix Pharmaceuticals (TNXP) - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali PEG SXTC|Pangali PEG Eupraxia Pharma (EPRX)|Rasio rega marang bathi tumrap wutah BioHarvest Sciences Inc. BHST|EXOZ - Pangali rega marang bathi tumrap wutah|ORMP: Pangali rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah ENTX (enterabio.com)|MindWalk Therapeutics (HYFT) - Rasio rega marang bathi tumrap wutah|Rega marang bathi kanthi panyesuaian wutah abvcpharma.com (ABVC)|Rasio rega marang bathi tumrap wutah Cumberland Pharma|Rasio rega marang bathi tumrap wutah QNTM|Pangali PEG FGEN|TELO (Telomir Pharma) - Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah Rani Therapeutics Holdings RANI|SNYR - Pangali rega marang bathi tumrap wutah|RLYB - Rasio rega marang bathi tumrap wutah|Kapitalisasi marang bathi resik kanthi nimbang wutah lexariabioscience.com LEXX|PULM: Pangali PEG|Rasio P/E diaturake wutah PTHL|Rasio rega marang bathi tumrap wutah Aptorum Group Limited|LYRA (Lyra Therapeutics, Inc.) - Rasio nilai perusahaan marang wutah bathi|Pangali PEG IBO|Kapitalisasi marang bathi resik kanthi nimbang wutah TNF Pharmaceuticals, Inc.|Pangali PEG YCBD (cbdMD, Inc.)|PRFX (PainReform Corp) - Rasio kapitalisasi marang bathi lan wutah|CYTO: Pangali rega marang bathi tumrap wutah|LIPO - Pangali PEG|OptiNose, Inc. (OPTN) - Rasio rega marang bathi tumrap wutah|PIRS - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio rega marang bathi tumrap wutah Procaps|Pangali rega marang bathi tumrap wutah Petros (PTPI)|Rasio rega marang bathi tumrap wutah Qilian International Corp (QLI)|Pangali PEG acelyrin.com (SLRN)|Pangali PEG TFFP (TFF Pharmaceuticals)